TherapeuticsMD, Inc (NASDAQ: TXMD) has market worth of 1.60B along 238.08M outstanding shares. The stock moved 1.21% to $6.7 in recent session. The recent traded volume was 2161328 shares. The stock had closed at $6.62 on the previous day.
In terms of profitability, TherapeuticsMD, Inc. has a gross margin of 85.20%, an operating margin of – and a net profit margin of -. Return on assets come to -62.60% and return on investment coming to -59.80% while Return on equity come to -80.70%.
Many Insiders have done trades inside the company. The Company has disclosed insider trading transaction to the Securities and Exchange Commission (SEC). The Finizio Robert G; CEO of TherapeuticsMD, Inc. sold 92000 shares at value of $6.67 on 21 Sep 2018. The Insider selling transaction had a total value worth of $613640. After the selling activity, now Finizio Robert G directly owns 18393559 shares of the company’s stock, valued at approximately $123236845.3. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing on 24 Sep 2018.
TherapeuticsMD, Inc.’s insider Finizio Robert G sold 92000 shares of the stock in a negotiation that occurred on 20 Sep 2018. The stock was sold at an average cost of S 6.58 per share, for a total transaction worth of $ 605360. The sale was disclosed in a legal filing with the Securities & Exchange Commission, on 24 Sep 2018.
In related news, Bernick Brian Director sold 91400 shares of the firm’s stock in a transaction that recorded on 13 Sep 2018. The stock was sold at an average price of $ 6.35 for a total value of $ 579933. After the negotiation, now Insider holds 6557371 shares of the company’s stock, valued at approximately $ 43934385.7.
Bernick Brian Director at TherapeuticsMD, Inc. also sold 91400 on 12 Sep 2018 at an average price of $ 6.26 for a total value of $ 571707. After the transaction, Bernick Brian owns 6557371 shares of the company’s stock, now priced at approximately $ 43934385.7. . The disclosure for this transaction can be found in SEC Form 4 submitted on 14 Sep 2018.
Additionally, Milligan John C.K. IV President/Secretary at the corporation sold 125000 shares for $ 765750 in a single transaction on 11 Sep 2018. Now, President/Secretary owns 1472419 shares worth of $ 9865207.3.
The stock has recorded a weekly performance of 9.12% and monthly performance is 18.37%. Shares have moved 0.00% over the last quarter and changed 33.47% over the recent six months. The shares registered yearly performance at 8.59% and YTD move seen at 10.93%.